GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TYK Medicines Inc (HKSE:02410) » Definitions » Total Stockholders Equity

TYK Medicines (HKSE:02410) Total Stockholders Equity : HK$500.83 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is TYK Medicines Total Stockholders Equity?

TYK Medicines's Total Stockholders Equity for the quarter that ended in Dec. 2024 was HK$500.83 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. TYK Medicines's Book Value per Share for the quarter that ended in Dec. 2024 was HK$1.35. The ratio of a company's debt over equity can be used to measure how leveraged this company is. TYK Medicines's Debt-to-Equity for the quarter that ended in Dec. 2024 was 0.38.

TYK Medicines Total Stockholders Equity Historical Data

The historical data trend for TYK Medicines's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TYK Medicines Total Stockholders Equity Chart

TYK Medicines Annual Data
Trend Dec22 Dec23 Dec24
Total Stockholders Equity
-564.99 -967.43 500.83

TYK Medicines Quarterly Data
Dec22 Mar23 Jun23 Dec23 Mar24 Jun24 Dec24
Total Stockholders Equity Get a 7-Day Free Trial - -967.43 -1,019.89 -1,126.60 500.83

TYK Medicines  (HKSE:02410) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

TYK Medicines's Book Value per Share for the quarter that ended in Dec. 2024 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(500.832-0)/370.836
=1.35

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

TYK Medicines's Debt-to-Equity for the quarter that ended in Dec. 2024 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(181.892 + 6.924) / 500.832
=0.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TYK Medicines Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of TYK Medicines's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

TYK Medicines Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TYK Medicines Inc (HKSE:02410) » Definitions » Total Stockholders Equity
Comparable Companies
HKSE:02629 HKSE:00775 HKSE:09966 HKSE:02105 HKSE:02157 HKSE:02142 HKSE:02315 HKSE:01672 HKSE:02256 HKSE:01477 VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
No.277 Longlan Road, 8th Floor, Building T2, China Eastern Binjiang Center, Xuhui District, Shanghai, CHN
Website
https://www.tykmedicines.com
TYK Medicines Inc is a clinical-stage biopharmaceutical company. The company is engaged in drug discovery research and development. The company and its subsidiaries are principally engaged in the research, development, and commercialization of pharmaceutical products. The company has built a pipeline with 12 drug candidates, including Core Product TY-9591, seven products in the clinical stage, and four products in the preclinical stage or early clinical development stage.
Executives
Nan Jing Yi Da Tou Zi Guan Li You Xian Gong Si
Nan Jing Yi Da Zi Ben Guan Li Qi Ye You Xian He Huo
Jiang Su Yi Da Gu Quan Tou Zi Ji Jin Guan Li You Xian Gong Si
Wu Yusheng 2201 Interest of corporation controlled by you
Zhu Julia Ming 2202 Interest of your spouse
Zheng Zhou Tai Ji Hong Nuo Yi Yao Gu Fen You Xian Gong Si 2101 Beneficial owner
Zhang Xing Li Yuan Qi Ye Guan Li He Huo Qi Ye You Xian He Huo 2101 Beneficial owner
He Chao 2201 Interest of corporation controlled by you
Bei Jing Hou Ji Jing Qiao Chuang Ye Tou Zi You Xian Gong Si 2201 Interest of corporation controlled by you
Bei Jing Rong Chen Hou Ji Tou Zi Guan Li You Xian Gong Si 2201 Interest of corporation controlled by you
Zhang Xing Xing Zhang Chan Ye Tou Zi He Huo Qi Ye You Xian He Huo 2101 Beneficial owner

TYK Medicines Headlines

No Headlines